Your browser doesn't support javascript.
loading
[Comparative cost-effectiveness analysis between darunavir/ritonavir and other protease inhibitors in treatment-naive human immunodeficiency syndrome type 1-infected patients in Spain]. / Análisis comparativo de coste-eficacia entre darunavir/ritonavir y otros inhibidores de la proteasa en el tratamiento de la infección por el virus de la inmunodeficiencia humana de tipo 1 en pacientes naïve en España.
Smets, Erik; Brogan, Anita J; Hill, Andrew; Adriaenssen, Ines; Sawyer, Anthony W; Domingo-Pedrol, Pere; Gostkorzewicz, Joana; Ledesma, Francisco.
Affiliation
  • Smets E; Johnson & Johnson Pharmaceutical Services LLC, Beerse, Bélgica.
Enferm Infecc Microbiol Clin ; 31(7): 430-6, 2013.
Article in Es | MEDLINE | ID: mdl-23260386
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Pyridines / Sulfonamides / HIV-1 / HIV Protease Inhibitors / Ritonavir / Lopinavir Type of study: Guideline / Health_economic_evaluation Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: Es Journal: Enferm Infecc Microbiol Clin Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2013 Document type: Article Country of publication: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Pyridines / Sulfonamides / HIV-1 / HIV Protease Inhibitors / Ritonavir / Lopinavir Type of study: Guideline / Health_economic_evaluation Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: Es Journal: Enferm Infecc Microbiol Clin Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2013 Document type: Article Country of publication: España